ATE257332T1 - Vitamin formulierung für kardiovaskuläre gesundheit - Google Patents
Vitamin formulierung für kardiovaskuläre gesundheitInfo
- Publication number
- ATE257332T1 ATE257332T1 AT00200967T AT00200967T ATE257332T1 AT E257332 T1 ATE257332 T1 AT E257332T1 AT 00200967 T AT00200967 T AT 00200967T AT 00200967 T AT00200967 T AT 00200967T AT E257332 T1 ATE257332 T1 AT E257332T1
- Authority
- AT
- Austria
- Prior art keywords
- cardiovascular health
- vitamin
- vitamin formulation
- composition
- high level
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 230000036996 cardiovascular health Effects 0.000 title abstract 2
- 229930003231 vitamin Natural products 0.000 title abstract 2
- 229940088594 vitamin Drugs 0.000 title abstract 2
- 235000013343 vitamin Nutrition 0.000 title abstract 2
- 239000011782 vitamin Substances 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title 1
- 150000003722 vitamin derivatives Chemical class 0.000 title 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 4
- 229930003427 Vitamin E Natural products 0.000 abstract 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 2
- 229940046009 vitamin E Drugs 0.000 abstract 2
- 235000019165 vitamin E Nutrition 0.000 abstract 2
- 239000011709 vitamin E Substances 0.000 abstract 2
- 239000007894 caplet Substances 0.000 abstract 1
- 230000006835 compression Effects 0.000 abstract 1
- 238000007906 compression Methods 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 150000004760 silicates Chemical class 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27181099A | 1999-03-18 | 1999-03-18 | |
| US51251200A | 2000-02-24 | 2000-02-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE257332T1 true ATE257332T1 (de) | 2004-01-15 |
Family
ID=26955120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00200967T ATE257332T1 (de) | 1999-03-18 | 2000-03-16 | Vitamin formulierung für kardiovaskuläre gesundheit |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1036510B1 (de) |
| JP (1) | JP2000281574A (de) |
| CN (1) | CN1271579A (de) |
| AT (1) | ATE257332T1 (de) |
| AU (1) | AU2232300A (de) |
| BR (1) | BR0001343A (de) |
| DE (1) | DE60007576D1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1216713A1 (de) * | 2000-12-20 | 2002-06-26 | Schering Aktiengesellschaft | Zusammensetzungen von Estrogen-Zyklodextrin Komplexe |
| FR2821748A1 (fr) * | 2001-03-12 | 2002-09-13 | Laurent Schwartz | Utilisation d'un principe actif anti-fibrose pour la preparation d'un medicamment destine a la prevention du cancer broncho-pulmonaire |
| JP4755353B2 (ja) * | 2001-04-02 | 2011-08-24 | 興和株式会社 | ビタミンｂ１製剤 |
| US6436431B1 (en) * | 2001-07-02 | 2002-08-20 | Diane Wright Hoffpauer | Fortified rice bran food product and method for promoting cardiovascular health |
| JP4965096B2 (ja) * | 2005-08-19 | 2012-07-04 | テバ製薬株式会社 | 圧縮成型製剤 |
| JP5249568B2 (ja) * | 2007-12-06 | 2013-07-31 | 旭化成ケミカルズ株式会社 | 成形用粉末、およびこれを用いた圧縮成形組成物、ならびに成形用粉末の製造方法 |
| US20110274791A1 (en) * | 2009-01-23 | 2011-11-10 | Wyeth Llc | Multivitamin/mineral formulation to combat the effects of environmental stress; improved immunity and improve energy while addressing vitamin and mineral deficiencies without the negative side effects of a mega dose nutritional supplement |
| NZ593506A (en) * | 2009-01-23 | 2013-09-27 | Wyeth Llc | Nutritional supplements for 50+ individuals for improving vitality, immunity, eye and bone health |
| EP2545788A1 (de) * | 2011-07-13 | 2013-01-16 | Martin Hulliger | Diätisches Mehrkomponentensystem |
| CN106901378A (zh) * | 2017-03-10 | 2017-06-30 | 深圳奥萨医疗有限公司 | 一种适用于女性的保健食品 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2858215A (en) * | 1956-07-02 | 1958-10-28 | Barnett Lab Inc | Process of preparing vitamin oils in particle form |
| US4603143A (en) * | 1983-05-02 | 1986-07-29 | Basf Corporation | Free-flowing, high density, fat soluble vitamin powders with improved stability |
| US4617294A (en) * | 1985-04-22 | 1986-10-14 | Ppg Industries, Inc. | Animal feed supplement |
| AU660630B2 (en) * | 1990-10-01 | 1995-07-06 | Brigham And Women's Hospital | Beta-carotene and vitamin E therapy for inhibition of major vascular events |
| JP4494539B2 (ja) * | 1997-02-28 | 2010-06-30 | ディーエスエム アイピー アセッツ ビー．ブイ． | 流動自由な乾燥粒子 |
-
2000
- 2000-03-16 AT AT00200967T patent/ATE257332T1/de not_active IP Right Cessation
- 2000-03-16 DE DE60007576T patent/DE60007576D1/de not_active Expired - Lifetime
- 2000-03-16 EP EP00200967A patent/EP1036510B1/de not_active Expired - Lifetime
- 2000-03-17 CN CN00106740A patent/CN1271579A/zh active Pending
- 2000-03-17 BR BR0001343-9A patent/BR0001343A/pt not_active IP Right Cessation
- 2000-03-17 JP JP2000081764A patent/JP2000281574A/ja active Pending
- 2000-03-17 AU AU22323/00A patent/AU2232300A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| BR0001343A (pt) | 2001-08-14 |
| EP1036510B1 (de) | 2004-01-07 |
| AU2232300A (en) | 2000-09-21 |
| DE60007576D1 (de) | 2004-02-12 |
| JP2000281574A (ja) | 2000-10-10 |
| CN1271579A (zh) | 2000-11-01 |
| EP1036510A2 (de) | 2000-09-20 |
| EP1036510A3 (de) | 2000-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2003059274A3 (en) | Vitamin formulation for cardiovascular health | |
| ATE257332T1 (de) | Vitamin formulierung für kardiovaskuläre gesundheit | |
| HUP0303621A3 (en) | Pharmaceutical compositions containing combinations comprising an antidiarrheal agent and epothilone or an epothilone | |
| EE200100618A (et) | Dieet- või farmatseutiline kompositsioon kasutamiseks hüperoksaluuria vältimiseks või raviks | |
| TR200101103T2 (tr) | CGMP PDE-İnhibitörü içeren kontrollu serbest bırakılan farmasötik formülasyonlar | |
| DE60219478D1 (en) | Orale gabe von 6-hydroxy-oxymorphon als analgetikum | |
| IL128942A0 (en) | Inhibitors of type 5 and type 3 17beta-hydroxysteroid dehydrogenase and pharmaceutical compositions containing the same | |
| MXPA03004818A (es) | Composicion conteniendo estatinas y calcio para salud cardiovascular mejorada. | |
| HK1069340A1 (en) | Orodispersible tablets containing fexofenadine | |
| HUP0003897A3 (en) | Pharmaceutical compositions containing an effervescent acid-base couple | |
| IL140338A0 (en) | Amino acid derivatives which inhibit dipeptidyl peptidase iv and pharmaceutical compositions containing the same | |
| ZA200200259B (en) | Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents. | |
| ZA200108260B (en) | A pharmaceutical formulation comprising an bisphosphonate and an additive agent providing an enhanced absorption of the bisphosphonate. | |
| HUP0104768A3 (en) | 4-amino-3-oxo-azepanes as protease inhibitors and pharmaceutical compositions containing the same | |
| NO332857B1 (no) | Inhalasjonskapsel samt anvendelse av slike | |
| NO914924D0 (no) | Direkte komrprimerbar pulverblanding samt fremgangsmaate ved fremstilling derav | |
| HUP0302160A3 (en) | Pharmaceutical compositions containing the combination of gaba agonists and sorbitol dehydrogenase inhibitors | |
| ES2052802T3 (es) | Composiciones farmaceuticas solubles en la boca que contienen acetilcisteina. | |
| HUP0102159A3 (en) | Pharmaceutical composition for the treatment of rumen acidosis | |
| IL151197A0 (en) | Thiazepinyl hydroxamic acid derivatives and pharmaceutical compositions containing the same | |
| HUP0203292A3 (en) | Health food useful for preventing liver and biliary dysfunctions containing an alkanoyl l-carnitine and silybum marianum extract | |
| MXPA00002462A (es) | Formulacion de vitamina para la salud cardiovascular. | |
| AU2001277786A1 (en) | Composition containing ginkgo biloba that inhibit angiogenesis and matrix metalloproteinase | |
| EP0948961A3 (de) | Calciumhaltige Brausetablette mit einem Antihistaminikum als Wirkstoff | |
| EP0316639A3 (en) | Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |